Aberdeen Group’s LivaNova LIVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$643K Sell
7,817
-18,033
-70% -$1.28M ﹤0.01% 867
2026
Q1
$1.64M Hold
25,850
﹤0.01% 780
2025
Q4
$1.59M Sell
25,850
-220,443
-90% -$12.6M ﹤0.01% 801
2025
Q3
$12.9M Sell
246,293
-80,493
-25% -$4.05M 0.02% 558
2025
Q2
$14.7M Buy
326,786
+50,076
+18% +$2.07M 0.03% 502
2025
Q1
$10.9M Buy
276,710
+44,685
+19% +$2M 0.02% 541
2024
Q4
$10.7M Hold
232,025
0.02% 498
2024
Q3
$12.2M Buy
232,025
+70,618
+44% +$3.5M 0.02% 481
2024
Q2
$8.85M Buy
161,407
+52,927
+49% +$3.02M 0.02% 534
2024
Q1
$6.07M Hold
108,480
0.01% 636
2023
Q4
$5.61M Buy
+108,480
New +$5.25M 0.01% 651

Other funds holding LIVN

Aberdeen Group's LIVN Position: Q2 2026 in Review

Aberdeen Group reduced its LivaNova (LIVN) stake by 70% in Q2 2026, selling an estimated $1.28M and leaving 7,817 shares worth $643K. The position accounts for ﹤0.01% of the portfolio, ranked #867.

Aberdeen Group first reported a position in LIVN in Q4 2023 and has held it in 11 quarters since. The position peaked at $14.7M in Q2 2025. 303 funds tracked by Wall St. Rank hold LIVN as of Q2 2026.

  • Aberdeen Group held 7,817 shares of LivaNova worth $643K as of Q2 2026.
  • Aberdeen Group sold 18,033 LivaNova shares in Q2 2026, an estimated $1.28M.
  • LivaNova made up ﹤0.01% of Aberdeen Group's portfolio in Q2 2026, its #867 holding.
  • Aberdeen Group first reported a position in LivaNova in Q4 2023 and has held it in 11 quarters since.
  • Aberdeen Group's LivaNova position peaked at $14.7M in Q2 2025.
  • 303 funds tracked by Wall St. Rank held LivaNova as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.